Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma
about
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro.Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals - Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry).Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer.Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer.Tamoxifen: the drug that came in from the cold.The economic consequences of breast cancer adjuvant hormonal treatments.Advances in the adjuvant and neoadjuvant treatment of breast cancer.
P2860
Q33477635-052D2B7C-1A95-43F7-B5B0-6674E1EC50D8Q33586637-72759B0F-19A6-4C25-89CE-BBB3ED373E21Q35909568-1010EBE9-2495-460D-A745-A57C241BFD40Q36823279-18E560BF-06BD-4872-8ED4-A7F566EB7149Q36950482-60084050-92C0-4CCE-A200-898680A90124Q37345339-D8EC8AB6-DF5A-457A-8CE4-61352064D63DQ37390094-4D419E7B-81F5-4F1B-A689-851F8093071EQ37608406-7EDD4052-4CDB-40BA-9719-8D7D278B9A29
P2860
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma
description
im März 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2007
@uk
name
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma
@en
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma
@nl
type
label
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma
@en
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma
@nl
prefLabel
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma
@en
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma
@nl
P2093
P356
P1433
P1476
Switching to an aromatase inhi ...... alysis of 2 consecutive trials
@en
P2093
Alessandra Rubagotti
Antonio Farris
Daniela Aldrighetti
Francesco Boccardo
Franco Buzzi
Giorgio Cruciani
Giorgio Mustacchi
Giorgio Schieppati
Mauro Porpiglia
P304
P356
10.1002/CNCR.22513
P407
P577
2007-03-01T00:00:00Z